Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 Mr. Douglas's Angiogram Gets a Second Look, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):28-34. doi: 10.1001/virtualmentor.2005.7.1.ccas6c-0501. Case and Commentary Jan 2000 Performing Physical Exams on Fellow Students Audiey Kao, MD, PhD Virtual Mentor. 2000;2(1):2-. doi: 10.1001/virtualmentor.2000.2.1.hlaw1-0001. Case and Commentary Feb 2017 How Should Therapeutic Decisions about Expensive Drugs Be Made in Imperfect Environments? Leonard M. Fleck, PhD and Marion Danis, MD Clinicians can be patient advocates, resource stewards, and promote good financial choices about care. AMA J Ethics. 2017;19(2):147-156. doi: 10.1001/journalofethics.2017.19.2.ecas2-1702. Case and Commentary Dec 1999 Disclosing the Truth about Medical Error Audiey Kao, MD, PhD Virtual Mentor. 1999;1(4):26-27. doi: 10.1001/virtualmentor.1999.1.4.hlaw1-9912. Case and Commentary Jan 2005 Mr. Douglas's Angiogram Gets a Second Look, Option Assessment Faith Lagay, PhD Virtual Mentor. 2005;7(1):28-34. doi: 10.1001/virtualmentor.2005.7.1.ccas6a-0501. Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Aug 2016 Is Consent to Autopsy Necessary? Cartesian Dualism in Medicine and Its Limitations Megan Lane and Christian J. Vercler, MD, MA The authors address the medical ethics question of whether autopsy is necessary from Cartesian and sociocultural perspectives and how to obtain consent. AMA J Ethics. 2016;18(8):771-778. doi: 10.1001/journalofethics.2016.18.8.ecas2-1608. Viewpoint Aug 2004 Neuroethics Martha J. Farah Virtual Mentor. 2004;372-375. doi: 10.1001/virtualmentor.2004.6.8.oped2-0408. In the Literature Aug 2016 Error Disclosure in Pathology and Laboratory Medicine: A Review of the Literature Ifeoma U. Perkins, MD A neglected topic in medical ethics is the unique barriers to error disclosure faced by anatomic and clinical pathologists. AMA J Ethics. 2016;18(8):809-816. doi: 10.1001/journalofethics.2016.18.8.nlit1-1608. Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725. Pagination First page « First Previous page ‹ Previous … Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Page 14 Page 15 … Next page Next › Last page Last »
Case and Commentary Jan 2005 Mr. Douglas's Angiogram Gets a Second Look, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):28-34. doi: 10.1001/virtualmentor.2005.7.1.ccas6c-0501.
Case and Commentary Jan 2000 Performing Physical Exams on Fellow Students Audiey Kao, MD, PhD Virtual Mentor. 2000;2(1):2-. doi: 10.1001/virtualmentor.2000.2.1.hlaw1-0001.
Case and Commentary Feb 2017 How Should Therapeutic Decisions about Expensive Drugs Be Made in Imperfect Environments? Leonard M. Fleck, PhD and Marion Danis, MD Clinicians can be patient advocates, resource stewards, and promote good financial choices about care. AMA J Ethics. 2017;19(2):147-156. doi: 10.1001/journalofethics.2017.19.2.ecas2-1702.
Case and Commentary Dec 1999 Disclosing the Truth about Medical Error Audiey Kao, MD, PhD Virtual Mentor. 1999;1(4):26-27. doi: 10.1001/virtualmentor.1999.1.4.hlaw1-9912.
Case and Commentary Jan 2005 Mr. Douglas's Angiogram Gets a Second Look, Option Assessment Faith Lagay, PhD Virtual Mentor. 2005;7(1):28-34. doi: 10.1001/virtualmentor.2005.7.1.ccas6a-0501.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Aug 2016 Is Consent to Autopsy Necessary? Cartesian Dualism in Medicine and Its Limitations Megan Lane and Christian J. Vercler, MD, MA The authors address the medical ethics question of whether autopsy is necessary from Cartesian and sociocultural perspectives and how to obtain consent. AMA J Ethics. 2016;18(8):771-778. doi: 10.1001/journalofethics.2016.18.8.ecas2-1608.
Viewpoint Aug 2004 Neuroethics Martha J. Farah Virtual Mentor. 2004;372-375. doi: 10.1001/virtualmentor.2004.6.8.oped2-0408.
In the Literature Aug 2016 Error Disclosure in Pathology and Laboratory Medicine: A Review of the Literature Ifeoma U. Perkins, MD A neglected topic in medical ethics is the unique barriers to error disclosure faced by anatomic and clinical pathologists. AMA J Ethics. 2016;18(8):809-816. doi: 10.1001/journalofethics.2016.18.8.nlit1-1608.
Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725.